We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-12.95%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$51.8B
AUM Growth
-$9.63B
Cap. Flow
-$699M
Cap. Flow %
-1.35%
Top 10 Hldgs %
15.72%
Holding
2,464
New
302
Increased
769
Reduced
979
Closed
219

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$792M
2
CA
CA, Inc.
CA
+$718M
3
V icon
Visa
V
+$129M
4
MA icon
Mastercard
MA
+$103M
5
EA icon
Electronic Arts
EA
+$98.7M

Sector Composition

Rank Sector Weight
1 Healthcare 18.67%
2 Financials 15.84%
3 Technology 11.21%
4 Industrials 8.66%
5 Energy 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRVN
2051
DELISTED
Trevena, Inc.
TRVN
$6K ﹤0.01%
+20
New +$11.3K
ZYNE
2052
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$6K ﹤0.01%
+1,900
New +$10.4K
SEAC
2053
DELISTED
Seachange International Inc
SEAC
$6K ﹤0.01%
231
-3,754
-94% -$120K
AGRX
2054
DELISTED
Agile Therapeutics
AGRX
$6K ﹤0.01%
+5
New +$7.66K
OTIC
2055
DELISTED
Otonomy, Inc.
OTIC
$6K ﹤0.01%
+3,300
New +$7.79K
NBEV
2056
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$6K ﹤0.01%
+1,100
New +$5.77K
MGLN
2057
DELISTED
Magellan Health Services, Inc.
MGLN
$6K ﹤0.01%
100
ADXS
2058
DELISTED
Advaxis Inc
ADXS
$6K ﹤0.01%
+2,127
New +$16.3K
BSTC
2059
DELISTED
BioSpecifics Technologies Corp.
BSTC
$6K ﹤0.01%
100
-100
-50% -$5.97K
GCAP
2060
DELISTED
Gain Capital Holdings, Inc.
GCAP
$6K ﹤0.01%
+900
New +$6.54K
TTPH
2061
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$6K ﹤0.01%
+255
New +$9.97K
AKRX
2062
DELISTED
Akorn Inc
AKRX
$6K ﹤0.01%
+1,800
New +$10.7K
JCP
2063
DELISTED
J.C. Penney Company, Inc.
JCP
$6K ﹤0.01%
+5,600
New +$7.85K
IDXG
2064
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$6K ﹤0.01%
+740
New +$8.88K
AREX
2065
DELISTED
Approach Resources Inc.
AREX
$6K ﹤0.01%
+6,700
New +$10.3K
HLTH
2066
DELISTED
Nobilis Health Corp.
HLTH
$6K ﹤0.01%
15,406
-74,155
-83% -$43.7K
SFS
2067
DELISTED
Smart & Final Stores, Inc.
SFS
$6K ﹤0.01%
+1,200
New +$6.62K
BRS
2068
DELISTED
Bristow Group, Inc.
BRS
$6K ﹤0.01%
+2,600
New +$19.7K
ACET
2069
DELISTED
Aceto Corp
ACET
$6K ﹤0.01%
7,500
MACK
2070
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$6K ﹤0.01%
+2,034
New +$7.05K
BAS
2071
DELISTED
Basis Energy Services, Inc.
BAS
$6K ﹤0.01%
1,600
-4,300
-73% -$31.5K
ALTO icon
2072
Alto Ingredients
ALTO
$360M
$5K ﹤0.01%
+6,124
New +$10.1K
AX icon
2073
Axos Financial
AX
$5.45B
$5K ﹤0.01%
200
-200
-50% -$6.03K
CGEN icon
2074
Compugen
CGEN
$216M
$5K ﹤0.01%
+2,500
New +$7.92K
DAKT icon
2075
Daktronics
DAKT
$941M
$5K ﹤0.01%
700
+200
+40% +$1.56K

Similar funds

Macquarie Group's Q4 2018 Portfolio in Review

As of Q4 2018, Macquarie Group held 2,464 positions worth $51.8B, down 16% from $61.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Macquarie Group's Q4 2018 filing shows 302 new, 769 increased, 979 reduced and 219 closed positions. Its largest new stake was Rapid7: 873,643 shares worth $27.2M. The largest sale was Express Scripts Holding Company, an estimated $792M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q4 2018 buy was Rapid7: 873,643 shares worth $27.2M.
  • Macquarie Group added most to Cigna in Q4 2018, an estimated $723M increase.
  • Macquarie Group's biggest Q4 2018 reduction was Visa, cutting an estimated $129M.
  • Macquarie Group fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $792M.
  • Macquarie Group's ten largest holdings make up 16% of its $51.8B portfolio in Q4 2018.
  • Macquarie Group opened 302 new positions and closed 219 in Q4 2018.
  • Macquarie Group's portfolio value fell 16% quarter-over-quarter to $51.8B.

Based on Macquarie Group's 13F filing for Q4 2018, filed 15 Feb 2019.